Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Tambralli

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|November 3, 2025
Neutrophils take center stage in VEXAS syndrome pathogenesisAjay Tambralli, Jason S Knight
Current Rheumatology Reports|August 27, 2020
NETs in APS: Current Knowledge and Future PerspectivesAjay Tambralli, Kelsey Gockman, Jason S Knight
Current Opinion in Rheumatology|February 21, 2025
Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in childrenKevin Lewis, Ajay Tambralli, Jacqueline A Madison
The Journal of Rheumatology|January 17, 2015
Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseasesAjay Tambralli, Timothy Beukelman, Randy Quentin Cron, et al.
Pediatric Rheumatology Online Journal|February 24, 2022
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case seriesJacqueline A Madison, Kelsey Gockman, Claire Hoy, et al.
Biofabrication|September 3, 2010
A hybrid biomimetic scaffold composed of electrospun polycaprolactone nanofibers and self-assembled peptide amphiphile nanofibersAjay Tambralli, Bryan Blakeney, Joel Anderson, et al.
Expert Review of Clinical Immunology|March 9, 2021
Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsetsIrene Cecchi, Massimo Radin, Javier Rodríguez-Carrio, et al.
The Journal of Rheumatology|August 17, 2013
High doses of infliximab in the management of juvenile idiopathic arthritisAjay Tambralli, Timothy Beukelman, Peter Weiser, et al.
Biomacromolecules|September 15, 2009
Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrixJoel M Anderson, Meenakshi Kushwaha, Ajay Tambralli, et al.
Biomaterials|November 30, 2010
Cell infiltration and growth in a low density, uncompressed three-dimensional electrospun nanofibrous scaffoldBryan A Blakeney, Ajay Tambralli, Joel M Anderson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|November 3, 2025
Neutrophils take center stage in VEXAS syndrome pathogenesisAjay Tambralli, Jason S Knight
Current Rheumatology Reports|August 27, 2020
NETs in APS: Current Knowledge and Future PerspectivesAjay Tambralli, Kelsey Gockman, Jason S Knight
Current Opinion in Rheumatology|February 21, 2025
Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in childrenKevin Lewis, Ajay Tambralli, Jacqueline A Madison
The Journal of Rheumatology|January 17, 2015
Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseasesAjay Tambralli, Timothy Beukelman, Randy Quentin Cron, et al.
Pediatric Rheumatology Online Journal|February 24, 2022
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case seriesJacqueline A Madison, Kelsey Gockman, Claire Hoy, et al.
Biofabrication|September 3, 2010
A hybrid biomimetic scaffold composed of electrospun polycaprolactone nanofibers and self-assembled peptide amphiphile nanofibersAjay Tambralli, Bryan Blakeney, Joel Anderson, et al.
Expert Review of Clinical Immunology|March 9, 2021
Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsetsIrene Cecchi, Massimo Radin, Javier Rodríguez-Carrio, et al.
The Journal of Rheumatology|August 17, 2013
High doses of infliximab in the management of juvenile idiopathic arthritisAjay Tambralli, Timothy Beukelman, Peter Weiser, et al.
Biomacromolecules|September 15, 2009
Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrixJoel M Anderson, Meenakshi Kushwaha, Ajay Tambralli, et al.
Biomaterials|November 30, 2010
Cell infiltration and growth in a low density, uncompressed three-dimensional electrospun nanofibrous scaffoldBryan A Blakeney, Ajay Tambralli, Joel M Anderson, et al.
Pageof 3